# FDA Inspection 1280216 - Noble Pharma, LLC - August 22, 2025

Source: https://www.keypedia.com/records/fda_inspections/noble-pharma-llc/9bd6b29d-79d2-4833-b195-e984fb7eadfb
Source feed: FDA_Inspections

> FDA Inspection 1280216 for Noble Pharma, LLC on August 22, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1280216
- Company Name: Noble Pharma, LLC
- Inspection Date: 2025-08-22
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Pre-Approval Evaluation of Animal Drugs and Food Additives
- Product Type: Animal Drugs & Feeds
- Office Name: Minneapolis District Office

## Related Documents

- [FDA Inspection 1280216 - 2025-08-22](https://www.keypedia.com/records/fda_inspections/noble-pharma-llc/d3d68f4a-a188-4a46-9301-743256ff5926)
- [FDA Inspection 1265315 - 2025-03-06](https://www.keypedia.com/records/fda_inspections/noble-pharma-llc/0102566b-edb9-41b3-ba29-ea012afe37a6)
- [FDA Inspection 1265315 - 2025-03-06](https://www.keypedia.com/records/fda_inspections/noble-pharma-llc/4923f155-0033-4862-abb1-444168dc5f5c)
- [FDA Inspection 1254963 - 2024-10-24](https://www.keypedia.com/records/fda_inspections/noble-pharma-llc/e9a96dd0-5a11-4598-9b63-6a8e73ed0792)
- [FDA Inspection 1254963 - 2024-10-24](https://www.keypedia.com/records/fda_inspections/noble-pharma-llc/7cbe0df4-8e9b-42bb-80dc-dd239d418f67)

Company: https://www.keypedia.com/companies/noble-pharma-llc/7fd1f37f-ba04-49a3-a115-ad7110e9f8a5

Office: https://www.keypedia.com/offices/minneapolis-district-office/c79fc8dc-f884-48fc-ba80-2947f662511d